Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €30.51 EUR
Change Today -0.35 / -1.13%
Volume 15.0
KO2 On Other Exchanges
Symbol
Exchange
EN Paris
Berlin
OTC US
As of 10:14 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

korian-medica (KO2) Snapshot

Open
€30.77
Previous Close
€30.86
Day High
€30.98
Day Low
€30.51
52 Week High
03/25/15 - €35.00
52 Week Low
08/11/14 - €25.43
Market Cap
2.4B
Average Volume 10 Days
5.2
EPS TTM
--
Shares Outstanding
79.0M
EX-Date
07/1/15
P/E TM
--
Dividend
€0.60
Dividend Yield
1.96%
Current Stock Chart for KORIAN-MEDICA (KO2)

Related News

No related news articles were found.

korian-medica (KO2) Related Businessweek News

No Related Businessweek News Found

korian-medica (KO2) Details

Korian-Medica provides temporary and permanent dependency care services in France, Germany, Belgium, and Italy. As of April 30, 2014, it managed 506 nursing homes; and 87 specialised post-acute care clinics, which has approximately 2,400 beds in intermediate residences, as well as provides homecare and residences services. The company also operates retirement homes, médicalisées, and rehabilitation and psychiatric clinics. Korian-Medica was founded in 2001 and is based in Paris, France.

40,000 Employees
Last Reported Date: 03/25/15
Founded in 2001

korian-medica (KO2) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: €654.0K
Compensation as of Fiscal Year 2013.

korian-medica (KO2) Key Developments

Korian-Medica Proposes Dividend for Financial Year 2014, Payable on July 24, 2015

Korian-Medica proposed at its AGM to be held on June 25, 2015, the payment of a dividend for financial year 2014 of €0.60 per share. Record date is June 30, 2015. Ex date is July 1, 2015. The dividend is payable on July 24, 2015.

Korian-Medica Announces Board Changes

Pursuant to the commitments undertaken upon the merger between Korian and Medica completed on 18 March 2014, Mr. Jacques Bailet retired from his positions of Member and Chairman of the Board of Directors of Korian-Medica. Mr. Christian Chautard, who held the position of Vice-Chairman of the Board of Directors since 18 March 2014, was appointed as Chairman of the Board of Directors in place of Mr. Jacques Bailet. Mr. Christian Chautard was Chairman of the Supervisory Board, and then of the Board of Directors of Korian from December 2011 until the date of the merger with Medica.

Korian-Medica Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014; Proposes Payment of Dividend

Korian-Medica reported audited consolidated earnings results for the year ended December 31, 2014. For the year on consolidated basis, revenue was EUR 2,222.2 million against EUR 1,356.4 million a year ago. EBITDA was EUR 315.1 million against EUR 181.2 million a year ago. Operating income was EUR 181.2 million against EUR 99.8 million a year ago. Profit before tax was EUR 64.5 million against EUR 55.1 million a year ago. Net profit was EUR 64.5 million against EUR 31.4 million a year ago. Net cash flow from operating activities was EUR 118.9 million against EUR 245.1 million a year ago. The company's net financial debt at December 31, 2014 amounted to EUR 1,474 million, including real estate debt of EUR 486 million. For the year on pro-forma basis, revenue was EUR 2,499.5 million against EUR 2,413.4 million a year ago. EBITDA was EUR 357.6 million against EUR 339.5 million a year ago. EBIT was EUR 247.9 million against EUR 230.4 million a year ago. Operating income was EUR 235.4 million against EUR 232.5 million a year ago. Net profit group share was EUR 112.8 million against EUR 92.5 million a year ago. At the next Shareholders' meeting on June 25, 2015, the company will propose the payment of a dividend of EUR 0.60 per share, with the option of a share-based payment.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KO2:GR €30.51 EUR -0.35

KO2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Generale de Sante SA €15.55 EUR -0.05
Le Noble Age €18.85 EUR -0.20
Maternus-Kliniken AG €0.74 EUR +0.027
Orpea €59.12 EUR -1.16
RHOEN-KLINIKUM AG €24.96 EUR -0.241
View Industry Companies
 

Industry Analysis

KO2

Industry Average

Valuation KO2 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 13.7x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KORIAN-MEDICA, please visit www.groupe-korian.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.